T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
This cohort study assesses the increase in second primary malignant neoplasms and T-cell malignant neoplasm cases associated with chimeric antigen receptor–T cells.
This cohort study assesses the increase in second primary malignant neoplasms and T-cell malignant neoplasm cases associated with chimeric antigen receptor–T cells.
Ray Blind, Ingram Assistant Professor of Cancer Research, was named associate director for diversity, equity, and inclusion at Vanderbilt-Ingram Cancer Center. To access this subscriber-only…
The FDA has granted traditional approval to tisotumab vedotin-tftv (Tivdak, Seagen [now part of Pfizer]) for recurrent or metastatic cervical cancer with disease progression on…
The PCAR study aimed to assess the efficacy and safety of preoperative transcatheter rectal arterial chemoembolisation (TRACE) in patients with locally advanced rectal cancer (LARC).
What is neuroblastoma? Neuroblastoma is a childhood cancer that develops when neural crest cells do not mature properly and continue to proliferate in an imm…
On April 30, 2024, the U.S. FDA granted Orphan Drug Designation to IGNK001, an investigational allogeneic NK cell therapy derived from healthy donors, for the…
Follow a few easy steps to create a free account on NCCN.org. • Go to the NCCN.org homepage. https://www.nccn.org/home Then, click on “Create Account.” •…
The 15 inductees have been selected by their peers for their remarkable achievements in oncology research and clinical practice.
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
Previous research suggests people with subjective cognitive decline are 2.5 times more likely to develop dementia.
OPTYX is a multi-center, prospective, observational study designed to further understand the actual experience of patients with advanced prostate cancer treated with relugolix (ORGOVYX®), an…